Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 3/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | USP30 | Q70CQ3 | 3/20 | 0.31 |
| ▸ | DRD4 | P21917 | 2/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346124 | 0.90 | CTSK (0.35) | CTSSCTSKUSP30DRD4HTR1A | |
| SCHEMBL31346074 | 0.82 | DPP4 (0.30) | — | |
| SCHEMBL31346014 | 0.77 | CTSS (0.47) | CTSSCTSK | |
| SCHEMBL31346087 | 0.76 | EZH2 (0.36) | CTSSCTSKUSP30DRD4LDHA | |
| SCHEMBL31346143 | 0.76 | LDHA (0.46) | DRD2LDHA | |
| SCHEMBL31346004 | 0.76 | DPP4 (0.31) | — | |
| SCHEMBL31346104 | 0.75 | DRD2 (0.34) | USP30DRD4DRD2 | |
| SCHEMBL31346027 | 0.75 | — | — | |
| SCHEMBL31346003 | 0.74 | CTSS (0.42) | CTSSCTSK | |
| SCHEMBL31346116 | 0.73 | LDHA (0.33) | LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |